×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
TheNewswire
(CSE:MYCO) (AQSE:MYIG) (FSE:0NFA) (OTC:MYCOF) (the “Company” or “Mydecine”) announces that it has entered into debt settlement agreements (the “Settlement...
1 month ago
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
GlobeNewswire
Mydecine developed several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns...
5 months ago
Mydecine Provides Q4 2023 Business Update
Yahoo Finance
VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO)...
6 months ago
Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement
Investing News Network
V ANCOUVER, BC MYDECINE INNOVATIONS GROUP INC . announces that it has closed a debt settlement to partially settle outstanding debts owed to a creditor for...
1 month ago
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 ...
GlobeNewswire
Mydecine received its second Notice of Allowance from the USPTO, on one of its novel compounds for Composition of Matter that is currently under...
3 months ago
Mydecine Chooses Equity Settlement to Preserve Capital - TipRanks.com
Tipranks
Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update. Mydecine Innovations Group Inc. has announced a strategic move to conserve cash by...
2 months ago
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting
InvestorsObserver
(TheNewswire) VANCOUVER, BC – TheNewswire - (May 1, 2024) Mydecine Innovations Group Inc . (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE:...
3 weeks ago
Mydecine Innovations Group Announces Director Resignation
GlobeNewswire
(“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE: 0NF0), a forefront biotechnology company dedicated to revolutionizing...
3 months ago
Mydecine Innovations Faces Trading Restrictions - TipRanks.com
Tipranks
Mydecine Innovations Group Inc. has received a Management Cease Trade Order (MCTO) due to a delay in filing its audited annual financial...
3 weeks ago